{"id":"CHEMBL105060","canonicalSmiles":"CN(C(=O)c1cc(C(F)(F)F)cc(C(F)(F)F)c1)[C@@H](/C=C/C(=O)N[C@@H]1CCCCNC1=O)Cc1ccc(Cl)c(Cl)c1","inchiKey":"BHCJHYIMNHXLOM-WVDRJWPYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DNK333","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Dnk333"],"count":3,"linkedTargets":{"rows":["ENSG00000115353"],"count":1},"linkedDiseases":{"rows":["EFO_0000555","EFO_0000341","EFO_0000274"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL105442","canonicalSmiles":"O=C(NOCC1CC1)c1ccc(F)c(F)c1Nc1ccc(I)cc1Cl","inchiKey":"GFMMXOIFOQCCGU-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CI-1040","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CI-1040","Ci 1040","Ci-1040","PD-18435","PD-184352"],"crossReferences":{"PubChem":["144206914","170466835","174006413"],"drugbank":["DB12429"]},"count":8,"linkedTargets":{"rows":["ENSG00000126934","ENSG00000169032"],"count":2},"linkedDiseases":{"rows":["EFO_0002618","EFO_0003869","EFO_0003860","MONDO_0008903","MONDO_0007254","EFO_0004142","EFO_0003060","EFO_1001951"],"count":8},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 8 investigational indications."}
{"id":"CHEMBL1069","canonicalSmiles":"CCCCC(=O)N(Cc1ccc(-c2ccccc2-c2nnn[nH]2)cc1)[C@H](C(=O)O)C(C)C","inchiKey":"ACWBQPMHZXGDFX-QFIPXVFZSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"VALSARTAN","yearOfFirstApproval":1996,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Diovan","Exforge","Prexxartan","Valsartan"],"synonyms":["CGP 48933","CGP-48933","Valsartan"],"crossReferences":{"DailyMed":["valsartan"],"PubChem":["26719825"],"Wikipedia":["Valsartan"],"drugbank":["DB00177"],"chEBI":["9927"]},"count":17,"approvedIndications":["EFO_0003144","EFO_0000373","EFO_0000612","EFO_0000319","EFO_0000537"],"linkedTargets":{"rows":["ENSG00000144891"],"count":1},"linkedDiseases":{"rows":["EFO_0004214","EFO_0003086","MONDO_0100130","MONDO_0002009","EFO_0000275","EFO_0000401","EFO_0000373","EFO_1001461","EFO_0000538","EFO_0005952","Orphanet_63","MONDO_0001302","EFO_0003914","EFO_0008585","EFO_0003144","EFO_0000712","EFO_0003884","EFO_1002032","EFO_0000400","EFO_0000407","EFO_0008586","HP_0002140","HP_0003124","EFO_0001645","EFO_0000319","EFO_0004194","Orphanet_309005","EFO_0000537","EFO_0003146","EFO_0000195","HP_0012664","MONDO_0100096","EFO_0008583","EFO_0000612","EFO_1001207","EFO_0001360","HP_0031273","HP_0012594","EFO_0005672"],"count":39},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1996 and has 5 approved and 12 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1079593","canonicalSmiles":"O=c1[nH]c2cnc(-n3cnc4ccc(F)cc43)nc2n1[C@@H]1CCOc2c(F)cccc21","inchiKey":"DBXGGXLBTWZXBB-MRXNPFEDSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"VS-5584","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["VS-5584","Vs 5584","Vs-5584"],"count":2,"linkedTargets":{"rows":["ENSG00000145675","ENSG00000171608","ENSG00000105647","ENSG00000141506","ENSG00000051382","ENSG00000121879","ENSG00000105851","ENSG00000117461","ENSG00000198793"],"count":9},"linkedDiseases":{"rows":["EFO_0000588","EFO_0000574","MONDO_0024880"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of I (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL108778","canonicalSmiles":"CC(C)C(=O)O","inchiKey":"KQNPFQTWMSNSAP-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ISOBUTYRIC ACID","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Isobutyric Acid"],"crossReferences":{"PubChem":["144208405"],"Wikipedia":["Isobutyric_acid"],"drugbank":["DB02531"],"chEBI":["16135"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1088","canonicalSmiles":"CN1CCCCC1CCN1c2ccccc2Sc2ccc([S+](C)[O-])cc21","inchiKey":"SLVMESMUVMCQIY-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"MESORIDAZINE","yearOfFirstApproval":1970,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Lidanar"],"synonyms":["Mesoridazine","NC-123","Serentil","TPS-23"],"crossReferences":{"PubChem":["144203603","144205571","170465272","26756521","447728"],"Wikipedia":["Mesoridazine"],"drugbank":["DB00933"],"chEBI":["6780"]},"childChemblIds":["CHEMBL1201052"],"count":1,"approvedIndications":["EFO_0005407"],"linkedTargets":{"rows":["ENSG00000149295","ENSG00000102468"],"count":2},"linkedDiseases":{"rows":["EFO_0005407"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1970 and is indicated for psychosis. This drug has a black box warning from the FDA."}
{"id":"CHEMBL109367","canonicalSmiles":"CC(C)C1=NCCc2ccc(NC(=O)c3ccc4cc(C(=N)N)ccc4c3)cc21","inchiKey":"XRHANBWAKSYPEN-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL109367","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB02473"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1100","canonicalSmiles":"CCC1(C)OC(=O)N(C)C1=O","inchiKey":"VQASKUSHBVDKGU-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PARAMETHADIONE","yearOfFirstApproval":1949,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Paradione"],"synonyms":["Isoethadione","Paramethadione"],"crossReferences":{"Wikipedia":["Paramethadione"],"drugbank":["DB00617"],"chEBI":["7921"]},"count":1,"approvedIndications":["EFO_0000474"],"linkedTargets":{"rows":["ENSG00000100346","ENSG00000006283","ENSG00000196557"],"count":3},"linkedDiseases":{"rows":["EFO_0000474"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1949 and is indicated for epilepsy."}
{"id":"CHEMBL113537","canonicalSmiles":"O=C(CCCCCCC(=O)C(F)(F)F)Nc1ccccc1","inchiKey":"KRCXZGYVOZSCSF-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL113537","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07553"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1159662","canonicalSmiles":"O[C@@H]1CO[C@@H](O)[C@H](O)[C@@H]1O","inchiKey":"SRBFZHDQGSBBOR-TXICZTDVSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"RIBOSE (PYRANOSE)","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["D-Ribose","Ribose","Ribose (pyranose)"],"crossReferences":{"Wikipedia":["Ribose"],"drugbank":["DB04286"],"chEBI":["27476"]},"count":3,"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL116455","canonicalSmiles":"O=C(O)CS","inchiKey":"CWERGRDVMFNCDR-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"THIOGLYCOLIC ACID","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Mercaptoacetic Acid","NSC-1894","Thioglycolic acid"],"crossReferences":{"PubChem":["144208915","144213623","68624"],"Wikipedia":["Thioglycolic_acid"],"drugbank":["DB15429"],"chEBI":["30065"]},"childChemblIds":["CHEMBL3187776"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL117651","canonicalSmiles":"Nc1ccc2c(c1)c(-c1ccccc1)[n+](CCCCCCc1cnnn1CCNc1c3c(nc4ccccc14)CCCC3)c1cc(N)ccc21","inchiKey":"ISUOMOOYAOQQPZ-UHFFFAOYSA-O","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL117651","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB03005"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1200407","canonicalSmiles":"CN[C@H]1[C@@H](O)[C@@H](NC)[C@H](O)[C@H]2O[C@@H]3O[C@H](C)CC(=O)[C@]3(O)O[C@H]12.Cl","inchiKey":"BIPVCOUVVAMJMZ-MTTMTQIXSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SPECTINOMYCIN HYDROCHLORIDE","maximumClinicalTrialPhase":0,"parentId":"CHEMBL1167","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Actinospectacin","Espectinomicina","Spectam","Stanilo","Trobicin"],"synonyms":["M-141","U-18409AE"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1200610","canonicalSmiles":"N[C@@H](C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(Cl)CC[C@H]12)c1ccccc1.O","inchiKey":"GPYKKBAAPVOCIW-HSASPSRMSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LORACARBEF","yearOfFirstApproval":1991,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1013","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Lorabid"],"synonyms":["LY-163892 MONOHYDRATE","LY163892 MONOHYDRATE","Loracarbef","Loracarbef monohydrate"],"crossReferences":{"PubChem":["144206680"]},"count":2,"approvedIndications":["EFO_0000771"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1991 and is indicated for bacterial disease and has 1 investigational indication."}
{"id":"CHEMBL1200628","canonicalSmiles":"CN[C@H](CC(C)C)C(=O)N[C@H]1C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]2C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c4cc(O)cc(O)c4-c4cc3ccc4O)[C@H](O)c3ccc(c(Cl)c3)Oc3cc2cc(c3O[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O[C@H]2C[C@](C)(N)[C@H](O)[C@H](C)O2)Oc2ccc(cc2Cl)[C@H]1O.Cl","inchiKey":"LCTORFDMHNKUSG-XTTLPDOESA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"VANCOMYCIN HYDROCHLORIDE","yearOfFirstApproval":1964,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL262777","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Firvanq kit","Vancocin","Vancocin hydrochloride","Vancocin matrigel","Vancoled","Vancomycin hydrochloride","Vancor","Vanoled"],"synonyms":["Vancomycin hydrochloride","Vancomycin monohydrochloride"],"crossReferences":{"DailyMed":["vancomycin%20hydrochloride"],"PubChem":["50107218"]},"count":6,"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1964 and has 6 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1200748","canonicalSmiles":"C[C@@](Cc1ccc(O)c(O)c1)(NN)C(=O)O.O","inchiKey":"QTAOMKOIBXZKND-PPHPATTJSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CARBIDOPA","yearOfFirstApproval":1975,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1201236","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Carbidopa","Lodosyn"],"synonyms":["Carbidopa","Carbidopa anhydrous","Carbidopa hydrate","Carbidopa monohydrate","Lodosyn","MK-486"],"crossReferences":{"DailyMed":["carbidopa"],"chEBI":["3395"]},"count":23,"approvedIndications":["EFO_1001175","EFO_1001402","EFO_0002508"],"linkedTargets":{"rows":["ENSG00000132437"],"count":1},"linkedDiseases":{"rows":["EFO_0003888","EFO_0002610","EFO_0005687","EFO_0001365","EFO_0002508","EFO_1000809","EFO_0005252","EFO_1001919","MONDO_0001020","EFO_0003768","Orphanet_55","HP_0003418","HP_0002381","Orphanet_72","EFO_0003843","EFO_0000537","Orphanet_791","EFO_0003885","EFO_1001175","Orphanet_1764","MONDO_0002050","EFO_1001402","EFO_0000712","EFO_0000270","EFO_0000253","MONDO_0001162","EFO_0000692"],"count":27},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1975 and has 3 approved and 20 investigational indications."}
{"id":"CHEMBL1200764","canonicalSmiles":"CC(=O)OC(C)C[N+](C)(C)C.[Cl-]","inchiKey":"JHPHVAVFUYTVCL-UHFFFAOYSA-M","drugType":"Small molecule","blackBoxWarning":true,"name":"METHACHOLINE CHLORIDE","yearOfFirstApproval":1986,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL978","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Provocholine"],"synonyms":["Methacholine chloride"],"crossReferences":{"DailyMed":["methacholine%20chloride"],"PubChem":["144203899","170464971","50105745","56423647","855729"],"chEBI":["50142"]},"count":1,"linkedTargets":{"rows":["ENSG00000133019"],"count":1},"linkedDiseases":{"rows":["EFO_0000270"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1986 and has 1 investigational indication. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1200831","canonicalSmiles":"CCOC(=O)[C@H](CCc1ccccc1)N[C@@H](C)C(=O)N1CC2(C[C@H]1C(=O)O)SCCS2.Cl","inchiKey":"CLDOLNORSLLQDI-OOAIBONUSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SPIRAPRIL HYDROCHLORIDE","yearOfFirstApproval":1994,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL431","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Renormax"],"synonyms":["SCH 33844","SCH-33844","Spirapril hydrochloride"],"crossReferences":{"PubChem":["144206534"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1994."}
{"id":"CHEMBL1200955","canonicalSmiles":"COc1c(C)c2c(c(O)c1C/C=C(\\C)CCC(=O)OCCN1CCOCC1)C(=O)OC2.Cl","inchiKey":"OWLCGJBUTJXNOF-HDNKIUSMSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"MYCOPHENOLATE MOFETIL HYDROCHLORIDE","yearOfFirstApproval":1998,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1456","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Cellcept","Mycophenolate mofetil hydrochloride"],"synonyms":["Mycophenolate mofetil hydrochloride","RS-61443-190"],"crossReferences":{"DailyMed":["mycophenolate%20mofetil%20hydrochloride"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1998. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1201131","canonicalSmiles":"CCCCOCCOCCOCc1cc2c(cc1CCC)OCO2","inchiKey":"FIPWRIJSWJWJAI-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PIPERONYL BUTOXIDE","yearOfFirstApproval":2000,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Piperonyl butoxide"],"crossReferences":{"PubChem":["144204585","144214047","170464741","17389754"],"Wikipedia":["Piperonyl_butoxide"],"drugbank":["DB09350"],"chEBI":["32687"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 2000."}
{"id":"CHEMBL1201329","canonicalSmiles":"O=C1N(Cc2ccccc2)C2C[S+]3CCCC3C2N1Cc1ccccc1","inchiKey":"CHQOEHPMXSHGCL-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TRIMETHAPHAN","yearOfFirstApproval":1982,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Trimetaphan","Trimethaphan"],"crossReferences":{"drugbank":["DB01116"],"chEBI":["9728"]},"childChemblIds":["CHEMBL1245"],"count":2,"approvedIndications":["EFO_0000537"],"linkedTargets":{"rows":["ENSG00000080644","ENSG00000117971"],"count":2},"linkedDiseases":{"rows":["EFO_0002614","EFO_1001461","EFO_0000537"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1982 and is indicated for hypertension and has 1 investigational indication."}
{"id":"CHEMBL1201368","canonicalSmiles":"CCC[C@H](N[C@@H](C)C(=O)N1[C@H](C(=O)O)C[C@@H]2CCCC[C@@H]21)C(=O)O","inchiKey":"ODAIHABQVKJNIY-PEDHHIEDSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PERINDOPRILAT","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Perindoprilat","S-9780"],"crossReferences":{"drugbank":["DB14213"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1201390","canonicalSmiles":"C[C@]12C[C@H](O)[C@@]3(F)[C@@H](C[C@H](F)C4=CC(=O)C=C[C@@]43C)[C@@H]1C[C@@H](O)[C@]2(O)C(=O)CO","inchiKey":"UUOUOERPONYGOS-CLCRDYEYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FLUOCINOLONE","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Fluocinolone"],"crossReferences":{"drugbank":["DB12553"],"chEBI":["5108"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL1201566","drugType":"Protein","blackBoxWarning":true,"name":"DARBEPOETIN ALFA","yearOfFirstApproval":2001,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Aranesp","Aranesp sureclick"],"synonyms":["Darbepoetin alfa","KRN-321","KRN321","NESP"],"crossReferences":{"DailyMed":["darbepoetin%20alfa"],"DrugCentral":["5157"]},"count":17,"approvedIndications":["EFO_0003884","EFO_0004272"],"linkedTargets":{"rows":["ENSG00000187266"],"count":1},"linkedDiseases":{"rows":["EFO_0000198","EFO_0003086","EFO_0001642","HP_0001919","EFO_0000403","MONDO_0007254","MONDO_0003002","EFO_0000311","EFO_1001951","EFO_0000565","EFO_0000095","EFO_0003884","MONDO_0005299","EFO_0000702","EFO_0000574","EFO_0004272","EFO_0008583","EFO_0000612","MONDO_0043510"],"count":19},"description":"Protein drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2001 and is indicated for chronic kidney disease and anemia (phenotype) and has 15 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL120708","canonicalSmiles":"CCCCn1c(=O)n(Cc2ccccc2F)c(=O)c2[nH]c(Cc3ccc(NC(C)=O)cc3)nc21","inchiKey":"JHSHXKJSPVHPCJ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL120708","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["137275974"],"drugbank":["DB02008"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1229677","canonicalSmiles":"CC(C)CCC(=O)N1CCC[C@H]1C(=O)NCc1cccc(Cl)c1","inchiKey":"PQUULPKGCNPPBX-INIZCTEOSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1229677","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB06868"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1230662","canonicalSmiles":"CN[C@@H](C)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H]1CCCc2ccccc21)C(C)(C)C","inchiKey":"JUJIMRZGUBTJRV-NASSWSRMSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1230662","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB02628"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1231545","canonicalSmiles":"Cc1cccc2c1C(=O)N(c1cc(-c3ccccc3)ccc1O)C2=O","inchiKey":"ROMNEYAQUBNRLR-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1231545","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07507"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1232305","canonicalSmiles":"Nc1ccn([C@H]2CC[C@@H](COP(=O)(O)O)O2)c(=O)n1","inchiKey":"RAJMXAZJKUGYGW-POYBYMJQSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1232305","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB02883"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1233057","canonicalSmiles":"COP(=O)(N[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O)OC","inchiKey":"LJBUJRWZZYUNKX-JAJWTYFOSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1233057","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB03392"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1233867","canonicalSmiles":"O=c1cc(-c2ccccc2)c2ccc(O)c(O)c2o1","inchiKey":"JRVIIPJSVKTPBK-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DNDI1417012","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["DNDI1417012"],"crossReferences":{"drugbank":["DB08049"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1235837","canonicalSmiles":"CC1(C)COC(=O)CCCCCCCCCCCOC(=O)[C@@H]2CCCCN2C(=O)C1=O","inchiKey":"VUCSBBBCFXBFFY-IBGZPJMESA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1235837","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08520"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1236104","canonicalSmiles":"O=C(O)CCC(=O)Nc1ccc(Br)cn1","inchiKey":"XFYYQDHEDOXWGA-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1236104","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["845483"],"drugbank":["DB08578"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL124660","canonicalSmiles":"COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1","inchiKey":"UXXQOJXBIDBUAC-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TANDUTINIB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CT 53518","CT-53518","CT53518","MLN-518","Mln-0518","Tandutinib"],"crossReferences":{"PubChem":["103905342","124950156","144206917","170466826","50100108"],"drugbank":["DB05465"],"chEBI":["90237"]},"count":8,"linkedTargets":{"rows":["ENSG00000113721","ENSG00000157404","ENSG00000122025"],"count":3},"linkedDiseases":{"rows":["EFO_0000198","EFO_0000630","EFO_0000349","EFO_1001465","EFO_0000222","EFO_0002499","EFO_0002501","EFO_0000519"],"count":8},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 8 investigational indications."}
{"id":"CHEMBL1255746","canonicalSmiles":"Cl.Oc1noc2c1CCNC2","inchiKey":"ZDZDSZQYRBZPNN-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"THIP HYDROCHLORIDE","maximumClinicalTrialPhase":0,"parentId":"CHEMBL312443","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["THIP HCl"],"crossReferences":{"PubChem":["50107170","56463588"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1257078","canonicalSmiles":"CC(C)COCC(CN(Cc1ccccc1)c1ccccc1)N1CCCC1.Cl","inchiKey":"JXBBWYGMTNAYNM-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1257078","maximumClinicalTrialPhase":0,"parentId":"CHEMBL1008","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["11532899","26747457","26747458","50105962","50105963","50105964","56322751"],"chEBI":["52712"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL126506","canonicalSmiles":"COc1cc(CC(C)N)cc2c1OCO2","inchiKey":"YQYUWUKDEVZFDB-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL126506","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB01442"]},"childChemblIds":["CHEMBL2361340"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1289110","canonicalSmiles":"CN1c2ccccc2C(NCCCCCCC(=O)O)c2ccc(Cl)cc2S1(=O)=O","inchiKey":"JICJBGPOMZQUBB-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TIANEPTINE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["JNJ-39823277","Jnj-39823277","S-1574","TPI-1062","Tianeptine"],"crossReferences":{"Wikipedia":["Tianeptine"],"drugbank":["DB09289"]},"childChemblIds":["CHEMBL2361572"],"count":2,"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL1318287","canonicalSmiles":"C[N+]1(CCCCC[N+]2(C)CCCC2)CCCC1.O=C([O-])[C@H](O)[C@@H](O)C(=O)O.O=C([O-])[C@H](O)[C@@H](O)C(=O)O","inchiKey":"HSMKTIKKPMTUQH-WBPXWQEISA-L","drugType":"Small molecule","blackBoxWarning":false,"name":"PENTOLINIUM TARTRATE","yearOfFirstApproval":1982,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1271","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Ansolysen"],"synonyms":["Pentolinium tartrate","Pentolonium tartrate","Pentolonum bitartrate"],"crossReferences":{"PubChem":["50106735","90341731"],"chEBI":["55326"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1982."}
{"id":"CHEMBL1322884","canonicalSmiles":"CC(C)=CC1C(C(=O)OCc2cccc(Oc3ccccc3)c2)C1(C)C","inchiKey":"SBNFWQZLDJGRLK-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PHENOTHRIN","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Full marks"],"synonyms":["Phenothrin","S-2539F","Sumithrin"],"crossReferences":{"PubChem":["144204849","144211887","170465585","26747802"],"Wikipedia":["Phenothrin"],"drugbank":["DB13717"],"chEBI":["34916"]},"count":1,"approvedIndications":["EFO_0001067"],"description":"Small molecule drug with a maximum clinical trial phase of IV and is indicated for parasitic infection."}
{"id":"CHEMBL1365675","canonicalSmiles":"Cc1ccc(/N=C/N(C)/C=N/c2ccc(C)cc2C)c(C)c1","inchiKey":"QXAITBQSYVNQDR-ZIOPAAQOSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AMITRAZ","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Amitraz","U-36,059"],"crossReferences":{"PubChem":["144204851","144208555","144211247","170465703","26747826","26753711"],"Wikipedia":["Amitraz"],"drugbank":["DB11373"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1402684","canonicalSmiles":"CC(=O)Oc1ccc(C2(c3ccc(OC(C)=O)cc3)C(=O)Nc3ccccc32)cc1","inchiKey":"PHPUXYRXPHEJDF-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"OXYPHENISATIN ACETATE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":true,"isApproved":true,"withdrawnNotice":{"countries":["Australia"," Germany"," France"," United Kingdom"," United States"],"classes":["Hepatotoxicity"],"year":1971},"tradeNames":["Isocrin","Lavema","Veripaque"],"synonyms":["Acetphenolisatin","Oxyphenisatin acetate","Oxyphenisatine"],"crossReferences":{"PubChem":["144205204","144205205","170466798","26754500","29215359"],"drugbank":["DB14627"]},"count":1,"approvedIndications":["HP_0002019"],"description":"Small molecule drug with a maximum clinical trial phase of IV and is indicated for constipation. It was withdrawn in Australia,  Germany,  France,  United Kingdom and  United States initially in 1971 due to Hepatotoxicity."}
{"id":"CHEMBL1411693","canonicalSmiles":"COc1cc(C)nc(-n2nc(C)cc2OC)n1","inchiKey":"RHAXSHUQNIEUEY-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"EPIRIZOLE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["DA-398","Epirizole","Mepirizole","Methopyrimazole"],"crossReferences":{"PubChem":["11112646","11532970","144204135","170465827"],"drugbank":["DB08991"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL144673","canonicalSmiles":"CCCCC(CC)CN1CN(CC(CC)CCCC)CC(C)(N)C1","inchiKey":"DTOUUUZOYKYHEP-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"HEXETIDINE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Oraldene","Sterisil"],"synonyms":["Hexetidine","Hexopyrimidine","NSC-17764"],"crossReferences":{"PubChem":["144203975","170465729","26748327","93576718"],"drugbank":["DB08958"]},"count":1,"approvedIndications":["EFO_0000544"],"description":"Small molecule drug with a maximum clinical trial phase of IV and is indicated for infection."}
{"id":"CHEMBL1457","canonicalSmiles":"COc1ccc2c3c1O[C@H]1C(=O)CC[C@H]4[C@@H](C2)N(C)CC[C@]314","inchiKey":"LLPOLZWFYMWNKH-CMKMFDCUSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"HYDROCODONE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Hydrocodone"],"crossReferences":{"DailyMed":["hydrocodone%20bitartrate"],"PubChem":["29215221"],"Wikipedia":["Hydrocodone"],"drugbank":["DB00956"],"chEBI":["5779"]},"childChemblIds":["CHEMBL3989677","CHEMBL1201470","CHEMBL3182640","CHEMBL2062267","CHEMBL2135756"],"count":11,"approvedIndications":["HP_0012735"],"linkedTargets":{"rows":["ENSG00000116329","ENSG00000082556","ENSG00000112038"],"count":3},"linkedDiseases":{"rows":["EFO_0005762","EFO_0003086","HP_0012532","HP_0012735","EFO_0010072","EFO_0003843","HP_0002018","EFO_0000546","EFO_0003966","EFO_0003890","EFO_0002506","EFO_0001421","HP_0003419","HP_0002013","EFO_0005611","EFO_1001250","EFO_0009615"],"count":17},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and is indicated for cough and has 10 investigational indications."}
{"id":"CHEMBL1463345","canonicalSmiles":"C[C@]12CC[C@H]3[C@@H](C=CC4=CC(=O)CC[C@@]43C)[C@@H]1CC[C@@]21CCC(=O)O1","inchiKey":"UJVLDDZCTMKXJK-WNHSNXHDSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CANRENONE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":true,"isApproved":true,"withdrawnNotice":{"countries":["Germany"],"classes":["Carcinogenicity"],"year":1986},"tradeNames":[],"synonyms":["Canrenone","NSC-261713","SC-9376","Spironolactone related compound a"],"crossReferences":{"PubChem":["144205004","170466206","49646110"],"drugbank":["DB12221"]},"count":1,"approvedIndications":["EFO_0000319"],"linkedTargets":{"rows":["ENSG00000151623"],"count":1},"linkedDiseases":{"rows":["EFO_0000275","EFO_1002032","EFO_0000319"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of IV and is indicated for cardiovascular disease. It was withdrawn in Germany  in 1986 due to Carcinogenicity."}
{"id":"CHEMBL1480","canonicalSmiles":"CCOC(=O)C1=C(C)NC(C)=C(C(=O)OC)C1c1cccc(Cl)c1Cl","inchiKey":"RZTAMFZIAATZDJ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FELODIPINE","yearOfFirstApproval":1991,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Cabren","Cardioplen xl","Felodipine","Felogen xl","Felotens xl","Folpik xl","Keloc sr","Neofel xl","Parmid xl","Pinefeld xl","Plendil","Preslow","Vascalpha"],"synonyms":["C08CA02","Felodipine","H 154/82","H-154/82"],"crossReferences":{"DailyMed":["felodipine"],"PubChem":["124880165","144203706","170464849","17405071","50106289","50106290","85231057","90340828"],"Wikipedia":["Felodipine"],"drugbank":["DB01023"],"chEBI":["585948"]},"count":5,"approvedIndications":["EFO_0000319","EFO_0000537"],"linkedTargets":{"rows":["ENSG00000157388","ENSG00000081248","ENSG00000151067","ENSG00000102001","ENSG00000151623"],"count":5},"linkedDiseases":{"rows":["EFO_0003914","HP_0003124","EFO_0001645","EFO_0000319","EFO_0001360","EFO_0000537"],"count":6},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1991 and is indicated for hypertension and cardiovascular disease and has 3 investigational indications."}
{"id":"CHEMBL1488","canonicalSmiles":"O=c1[nH]cc(N(CCCl)CCCl)c(=O)[nH]1","inchiKey":"IDPUKCWIGUEADI-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"URACIL MUSTARD","yearOfFirstApproval":1962,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Uracil mustard"],"synonyms":["U-8344","Uracil mustard","Uramustine"],"crossReferences":{"PubChem":["144205464","29216259","92079"],"Wikipedia":["Uramustine"],"drugbank":["DB00791"],"chEBI":["9884"]},"count":1,"approvedIndications":["EFO_0000616"],"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1962 and is indicated for neoplasm."}
{"id":"CHEMBL154","canonicalSmiles":"COc1ccc2cc([C@H](C)C(=O)O)ccc2c1","inchiKey":"CMWTZPSULFXXJA-VIFPVBQESA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"NAPROXEN","yearOfFirstApproval":1976,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Aleve","Anaprox","Arthrosin 250","Arthrosin 250 ec","Arthrosin 500","Arthrosin 500 ec","Condrotec","Ec-naprosyn","Equiproxen","Feminax ultra","Grenoxal","Kenosyn","Laraflex","Napratec op","Naprosyn","Naprosyn 375","Naprosyn ec","Naproxen","Nycopren","Pranoxen continus","Prosaid","Rheuflex 250","Rheuflex 500","Rimoxyn","Stirlescent","Timpron","Timpron 250 ec","Timpron 500 ec","Valrox","Vimovo"],"synonyms":["Aleve","Anaprox","Naprelan","Naproxen","PN400 COMPONENT NAPROXEN","RS-3540"],"crossReferences":{"DailyMed":["naproxen","naproxen%20sodium"],"PubChem":["11112669","144212270","26755231","90341518"],"TG-GATEs":["73"],"Wikipedia":["Naproxen"],"drugbank":["DB00788"],"chEBI":["7476"]},"childChemblIds":["CHEMBL1200806"],"count":29,"approvedIndications":["HP_0002829","EFO_0009454","EFO_0000685","HP_0003326","EFO_0002506","EFO_0004274","EFO_0003898","HP_0100607","EFO_0003843","EFO_0005755","EFO_0005757","EFO_0002609"],"linkedTargets":{"rows":["ENSG00000073756","ENSG00000095303"],"count":2},"linkedDiseases":{"rows":["EFO_1001896","EFO_0004274","EFO_0000249","MONDO_0007254","HP_0000132","HP_0011868","EFO_0003964","HP_0004398","HP_0002829","EFO_0003931","EFO_0002506","EFO_1000786","EFO_0000673","EFO_0004616","HP_0003419","EFO_0005762","Orphanet_144","EFO_0000685","Orphanet_609","EFO_0003821","EFO_0010072","EFO_0003898","HP_0003418","EFO_0004607","EFO_0003843","EFO_0005755","HP_0002315","EFO_0002609","EFO_1000941","EFO_0005757","EFO_0000546","EFO_0009454","HP_0003326","EFO_0003885","MP_0001845","MONDO_0100096","EFO_0000731","HP_0002653","HP_0100607","MONDO_0002258","EFO_1001887","EFO_1001434","EFO_0009637"],"count":43},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1976 and has 12 approved and 17 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1614652","canonicalSmiles":"O=C1c2ccccc2S(=O)(=O)N1CCCCNC[C@H]1CCc2ccccc2O1","inchiKey":"YGYBFMRFXNDIPO-QGZVFWFLSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"REPINOTAN","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Repinotan"],"crossReferences":{"Wikipedia":["Repinotan"],"drugbank":["DB06506"]},"description":"Small molecule drug with a maximum clinical trial phase of II."}
{"id":"CHEMBL163672","canonicalSmiles":"CCOC(=O)COc1ccc2c(C)c(CCN(CC)CC)c(=O)oc2c1","inchiKey":"KLOIYEQEVSIOOO-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHROMONAR","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Carbocromen"],"crossReferences":{"Wikipedia":["Carbocromen"],"drugbank":["DB13279"]},"childChemblIds":["CHEMBL2104512"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL1672635","canonicalSmiles":"Cc1c(N[C@@H](c2nnc(-c3ccc(C#N)cc3)o2)[C@H](C)O)ccc(C#N)c1Cl","inchiKey":"XMBUPPIEVAFYHO-KPZWWZAWSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"RAD-140","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["RAD-140","RAD140","Rad-140","Rad140","Vosilasarm"],"crossReferences":{"drugbank":["DB13939"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL1689063","canonicalSmiles":"NC(=O)[C@@H]1CC[C@@H]2CN1C(=O)N2OS(=O)(=O)O","inchiKey":"NDCUAPJVLWFHHB-UHNVWZDZSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AVIBACTAM","yearOfFirstApproval":2015,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Nxl-104"],"synonyms":["Avibactam","NXL104"],"crossReferences":{"DailyMed":["avibactam%20sodium"],"drugbank":["DB09060"],"chEBI":["85984"]},"childChemblIds":["CHEMBL2107817"],"count":6,"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2015 and has 6 investigational indications."}
{"id":"CHEMBL169046","canonicalSmiles":"C[C@H](CCCC(C)(C)O)[C@H]1CC[C@H]2[C@@H]3CC=C4C[C@@H](O)CC[C@]4(C)[C@H]3CC[C@@]21C","inchiKey":"INBGSXNNRGWLJU-ZHHJOTBYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"25-Hydroxycholesterol","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["25-Hydroxycholesterol"],"crossReferences":{"PubChem":["144206343","50125921"],"drugbank":["DB04705"],"chEBI":["42977"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1697771","canonicalSmiles":"O=C(NC(Cc1cc(=O)[nH]c2ccccc12)C(=O)O)c1ccc(Cl)cc1","inchiKey":"ALLWOAVDORUJLA-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"REBAMIPIDE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["OPC-12759","Rebamipide"],"crossReferences":{"PubChem":["144205013","170465891","174006202","26749027"],"Wikipedia":["Rebamipide"],"drugbank":["DB11656"]},"count":10,"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 10 investigational indications."}
{"id":"CHEMBL1697826","canonicalSmiles":"CCCC(=O)c1ccc2c(c1)N(CCCN1CCN(C)CC1)c1ccccc1S2","inchiKey":"DVLBYTMYSMAKHP-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BUTAPERAZINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AHR-3000","BAYER 1362","Butaperazine","Butyrylperazine","RIKER 595"],"crossReferences":{"drugbank":["DB13213"]},"childChemblIds":["CHEMBL2106507"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL1697849","canonicalSmiles":"Clc1ccc(C/C(=C\\CN2CCCC2)c2ccccc2)cc1","inchiKey":"WDYYVNNRTDZKAZ-XDHOZWIPSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PYRROBUTAMINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Pyrrobutamine"],"childChemblIds":["CHEMBL3989488"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL1743071","drugType":"Antibody","blackBoxWarning":false,"name":"SIRUKUMAB","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CNTO 136","CNTO-136","Sirukumab"],"count":9,"linkedTargets":{"rows":["ENSG00000136244"],"count":1},"linkedDiseases":{"rows":["EFO_0003834","EFO_1001209","EFO_0000685","EFO_0005761","EFO_0008518","MONDO_0100096","EFO_0002690","MONDO_0002009","EFO_0000270","EFO_0000540"],"count":10},"description":"Antibody drug with a maximum clinical trial phase of III (across all indications) and has 9 investigational indications."}
{"id":"CHEMBL1743086","drugType":"Antibody","blackBoxWarning":false,"name":"VATELIZUMAB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["GBR 500","GBR-500","SAR-339658","SAR339658","Vatelizumab"],"count":2,"linkedTargets":{"rows":["ENSG00000164171"],"count":1},"linkedDiseases":{"rows":["EFO_0000729","EFO_0003929"],"count":2},"description":"Antibody drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL188185","canonicalSmiles":"CCCC(=O)N1CCCN(c2nc(N)c3cc(OC)c(OC)cc3n2)CC1","inchiKey":"RHLJLALHBZGAFM-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BUNAZOSIN","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Bunazosin","Bunazosin hydrochloride"],"crossReferences":{"Wikipedia":["Bunazosin"],"drugbank":["DB12230"]},"childChemblIds":["CHEMBL3182014"],"description":"Small molecule drug with a maximum clinical trial phase of III."}
{"id":"CHEMBL1902931","canonicalSmiles":"CSC(=O)c1c(C(F)F)nc(C(F)(F)F)c(C(=O)SC)c1CC(C)C","inchiKey":"YUBJPYNSGLJZPQ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DITHIOPYR","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["144211467","26757326"],"drugbank":["DB15230"],"chEBI":["81987"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1908370","canonicalSmiles":"N#Cc1c(N2C[C@@H]3NCCO[C@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12","inchiKey":"FYMHQCNFKNMJAV-HOTGVXAUSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FINAFLOXACIN","yearOfFirstApproval":2014,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Xtoro"],"synonyms":["AL-60371","Finafloxacin"],"crossReferences":{"drugbank":["DB09047"],"chEBI":["85176"]},"count":4,"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2014 and has 4 investigational indications."}
{"id":"CHEMBL1910411","canonicalSmiles":"CN(C)[C@H]1C[C@@H](C(C)(C)CO)Nc2ccc([N+](=O)[O-])cc21","inchiKey":"YNYAUBNZRZVNLX-KBPBESRZSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1910411","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB13938"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1933349","canonicalSmiles":"COc1ccc2cc(-c3cc(-c4cc(Cl)cc(Cl)c4)nn3[C@@H](C)c3ccc(C(=O)NCCC(=O)O)cc3)ccc2c1","inchiKey":"DNTVJEMGHBIUMW-IBGZPJMESA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MK-0893","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["MK-0893","Mk-0893"],"crossReferences":{"drugbank":["DB12044"]},"childChemblIds":["CHEMBL2159354"],"count":1,"linkedTargets":{"rows":["ENSG00000215644"],"count":1},"linkedDiseases":{"rows":["EFO_0001360"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL1961797","canonicalSmiles":"CCCCCNC(=O)N1CCC(CN(Cc2ccc(Cl)cc2)Cc2ccc([N+](=O)[O-])s2)C1","inchiKey":"PPUYOYQTTWJTIU-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SR9011","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["174006959"],"drugbank":["DB14014"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL19892","canonicalSmiles":"O=c1[nH]c2cc(C(F)(F)F)c(N3CCOCC3)cc2n(CP(=O)(O)O)c1=O","inchiKey":"WZMQMKNCWDCCMT-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FANAPANEL","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Fanapanel","ZK-200775","ZK200775","Zk200775"],"crossReferences":{"PubChem":["144205298","170466123","29215531"],"drugbank":["DB12393"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2035185","canonicalSmiles":"C1=C/COCc2cc(ccc2OCCN2CCCC2)Nc2nccc(n2)-c2ccc(o2)COC/1","inchiKey":"NNXDIGHYPZHXTR-ONEGZZNKSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CT-1578","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CT-1578","SB-1578"],"crossReferences":{"drugbank":["DB15294"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL203569","canonicalSmiles":"NS(=O)(=O)c1ccc(Nc2cc(NC3CCCCC3)nc3ncnn23)cc1","inchiKey":"VPOGRVWIIVMWRI-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL203569","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07686"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2079699","drugType":"Small molecule","blackBoxWarning":false,"name":"SODIUM STIBOGLUCONATE","maximumClinicalTrialPhase":4,"parentId":"CHEMBL3991035","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Pentostam"],"synonyms":["Antimony sodium gluconate","Sodium stibogluconate","Sodium stibogluconate anhydrous"],"count":8,"approvedIndications":["DOID_10113","EFO_0005044"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and is indicated for trypanosomiasis and leishmaniasis and has 6 investigational indications."}
{"id":"CHEMBL207994","canonicalSmiles":"COc1cc(OC)c(NC(=O)Nc2cnc(C#N)cn2)cc1Cl","inchiKey":"URQYPXQXSVUVRG-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL207994","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07314"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2095208","canonicalSmiles":"CC(C)c1nc(CN(C)C(=O)N[C@@H](CCN2CCOCC2)C(=O)N[C@H](CC[C@H](Cc2ccccc2)NC(=O)OCc2cncs2)Cc2ccccc2)cs1","inchiKey":"ZCIGNRJZKPOIKD-CQXVEOKZSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"COBICISTAT","yearOfFirstApproval":2012,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Tybost"],"synonyms":["Cobicistat","GS-9350"],"crossReferences":{"DailyMed":["cobicistat"],"drugbank":["DB09065"],"chEBI":["72291"]},"count":8,"approvedIndications":["EFO_0000544","EFO_0000764","EFO_0000180"],"linkedTargets":{"rows":["ENSG00000160870","ENSG00000106258","ENSG00000160868","ENSG00000021461"],"count":4},"linkedDiseases":{"rows":["EFO_0000765","EFO_0007448","MONDO_0100096","EFO_0001068","EFO_0000544","EFO_0002614","EFO_0000764","EFO_0000180","EFO_0003060"],"count":9},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2012 and has 3 approved and 5 investigational indications."}
{"id":"CHEMBL2103912","canonicalSmiles":"O.O.O.O.O=P([O-])(O)C(O)(Cn1ccnc1)P(=O)([O-])O.[Na+].[Na+]","inchiKey":"IEJZOPBVBXAOBH-UHFFFAOYSA-L","drugType":"Small molecule","blackBoxWarning":false,"name":"ZOLEDRONATE DISODIUM","maximumClinicalTrialPhase":0,"parentId":"CHEMBL924","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CGP 42446A","Zoledronate disodium"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2103983","canonicalSmiles":"[K+].[OH-]","inchiKey":"KWYUFKZDYYNOTN-UHFFFAOYSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"POTASSIUM HYDROXIDE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["E-525","INS NO.525","INS-525","Potassium hydroxide"],"crossReferences":{"drugbank":["DB11153"],"chEBI":["32035"]},"description":"Small molecule drug with a maximum clinical trial phase of II."}
{"id":"CHEMBL2104318","canonicalSmiles":"O=S(=O)([O-])CCSSCCS(=O)(=O)[O-].[Na+].[Na+]","inchiKey":"KQYGMURBTJPBPQ-UHFFFAOYSA-L","drugType":"Small molecule","blackBoxWarning":false,"name":"DIMESNA","maximumClinicalTrialPhase":3,"parentId":"CHEMBL2009034","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Dimesna","NSC-716976"],"count":2,"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL2104668","canonicalSmiles":"CCC(CC)(CNC(=O)CCCO)c1cccc(OC)c1","inchiKey":"LMBMDLOSPKIWAP-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"EMBUTRAMIDE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Embutane","T-61"],"synonyms":["Embutramide","HOE 18 680"],"crossReferences":{"PubChem":["170465662"],"drugbank":["DB01487"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2105665","canonicalSmiles":"CCCCCCCC/C=C/CCCCCCCC(=O)OC[C@H]1O[C@@H](n2ccc(N)nc2=O)[C@@H](O)[C@@H]1O","inchiKey":"FLFGNMFWNBOBGE-FNNZEKJRSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ELACYTARABINE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CP 4055","CP-4055","Elacytarabine","P-4055"],"crossReferences":{"drugbank":["DB05494"]},"count":4,"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL2105707","canonicalSmiles":"CSCC[C@H](N)C(=O)N[C@@]1(C(=O)O)CS(=O)(=O)[C@H]2[C@H](C(=O)O)[C@H]21.O","inchiKey":"HQMAHCKDJKNYEK-LBMFEJOUSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"POMAGLUMETAD METHIONIL","maximumClinicalTrialPhase":0,"parentId":"CHEMBL2110730","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["LY2140023 MONOHYDRATE","Pomaglumetad methionil"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2106004","canonicalSmiles":"CC(=O)Oc1ccc(C2(c3ccc(OC(C)=O)cc3)Oc3ccccc3NC2=O)cc1","inchiKey":"ZCBJDQBSLZREAA-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BISOXATIN ACETATE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Bisoxatin","Bisoxatin acetate","WY-8138"],"crossReferences":{"PubChem":["144206872"],"drugbank":["DB14654"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2106613","canonicalSmiles":"CC(=O)OCC(=O)[C@@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)C3=CC[C@@]21C","inchiKey":"YUWPMEXLKGOSBF-GACAOOTBSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ANECORTAVE ACETATE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AL 3789","AL-3789","Anecortave","Anecortave acetate","NSC-15475","NSC-24345"],"crossReferences":{"PubChem":["144206221"],"drugbank":["DB05288"]},"count":9,"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 9 investigational indications."}
{"id":"CHEMBL2107783","canonicalSmiles":"O=C(O)COc1cccc(CN(Cc2ccc(-n3cccn3)cc2)S(=O)(=O)c2cccnc2)c1","inchiKey":"MFFBXYNKZHTCEY-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TAPRENEPAG","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Taprenepag"],"crossReferences":{"drugbank":["DB12623"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2107825","canonicalSmiles":"CC(C)OC(=O)[C@H](C)N[P@](=O)(CO[C@H](C)Cn1cnc2c(N)ncnc21)Oc1ccccc1","inchiKey":"LDEKQSIMHVQZJK-CAQYMETFSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"TENOFOVIR ALAFENAMIDE","yearOfFirstApproval":2015,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Gs-7340","Vemlidy"],"synonyms":["GS-7340","GS-734003","Tenofovir alafenamide"],"crossReferences":{"DailyMed":["tenofovir%20alafenamide%20fumarate"],"drugbank":["DB09299"]},"childChemblIds":["CHEMBL2364637"],"count":10,"approvedIndications":["EFO_0000763"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2015 and is indicated for viral disease and has 9 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL2108232","drugType":"Unknown","blackBoxWarning":false,"name":"COAL TAR","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Alphosyl","Aquatar","Capasal","Clinitar","Cocois co","Denorex","Fototar","Gelcotar","Genisol","Ionil t","Ionil-t","Ionil-t-plus","Neutrogena","Patterson's","Pentrax","Polytar af","Polytar plus","Pomade u.b.h.","Psoriderm","St johns","Stantar","Vanseb-t","Zetar"],"synonyms":["Coal tar","Coal tar solution","Coal tar, prepared"],"count":1,"description":"Unknown drug with a maximum clinical trial phase of IV and has 1 investigational indication."}
{"id":"CHEMBL2108989","drugType":"Enzyme","blackBoxWarning":false,"name":"ASPARAGINASE","yearOfFirstApproval":1994,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Crasnitin","Elspar"],"synonyms":["Asparaginase","Colaspase","L-asparaginase","NSC-109229"],"crossReferences":{"DrugCentral":["5070"]},"count":23,"approvedIndications":["EFO_0000616"],"description":"Enzyme drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1994 and is indicated for neoplasm and has 22 investigational indications."}
{"id":"CHEMBL2109465","drugType":"Antibody","blackBoxWarning":false,"name":"QAX-576","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Dectrekumab","QAX-576","Qax-576"],"count":8,"linkedTargets":{"rows":["ENSG00000169194"],"count":1},"linkedDiseases":{"rows":["EFO_0004232","EFO_0005854","EFO_0000270","EFO_0000768","EFO_0004212","EFO_0000717","EFO_0000384","EFO_0009448"],"count":8},"description":"Antibody drug with a maximum clinical trial phase of II (across all indications) and has 8 investigational indications."}
{"id":"CHEMBL2109495","drugType":"Antibody","blackBoxWarning":false,"name":"E2.3","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["E2.3"],"count":4,"linkedTargets":{"rows":["ENSG00000072274","ENSG00000106327"],"count":2},"linkedDiseases":{"rows":["EFO_0000565","EFO_0000198","EFO_0002428","EFO_0001378"],"count":4},"description":"Antibody drug with a maximum clinical trial phase of I (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL2109502","drugType":"Antibody","blackBoxWarning":false,"name":"SGN-15","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BMS-182248","BR-96 CBR96-DOXORUBICIN IMMUNOCONJUGATE","BR96","SGN-15","Sgn-15"],"count":4,"description":"Antibody drug with a maximum clinical trial phase of II (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL2109570","drugType":"Antibody","blackBoxWarning":false,"name":"SONEPCIZUMAB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["LT-1009","LT1009","Sonepcizumab"],"count":3,"description":"Antibody drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL2109633","drugType":"Antibody","blackBoxWarning":false,"name":"IMGN-388","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["IMGN-388","Imgn-388"],"count":1,"linkedTargets":{"rows":["ENSG00000138448"],"count":1},"linkedDiseases":{"rows":["EFO_0000616"],"count":1},"description":"Antibody drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2110561","drugType":"Small molecule","blackBoxWarning":false,"name":"SAMARIUM LEXIDRONAM PENTASODIUM","yearOfFirstApproval":1997,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":[],"crossReferences":{"DailyMed":["samarium%20sm-153%20lexidronam%20pentasodium"]},"childChemblIds":["CHEMBL2096660"],"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1997."}
{"id":"CHEMBL2111100","canonicalSmiles":"CCCCCCCCCCCCCCCC(=O)OC[C@H](COP(=O)(O)OCCNC(=O)[C@H](C)NC(=O)CC[C@@H](NC(=O)[C@H](C)NC(=O)[C@@H](C)O[C@H]1[C@H](O)[C@@H](CO)OC(O)[C@@H]1NC(C)=O)C(N)=O)OC(=O)CCCCCCCCCCCCCCC","inchiKey":"JMUHBNWAORSSBD-WKYWBUFDSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MIFAMURTIDE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["L-MTP-PE","Mifamurtide"],"childChemblIds":["CHEMBL2107354"],"linkedTargets":{"rows":["ENSG00000167207"],"count":1},"linkedDiseases":{"rows":["EFO_0000637"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV."}
{"id":"CHEMBL2146104","canonicalSmiles":"CC(N)C(O)c1ccccc1.O=C(O)C(O)C(O)C(=O)O","inchiKey":"NCHHVLCKEUNWNJ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PHENYLPROPANOLAMINE BITARTRATE","maximumClinicalTrialPhase":0,"parentId":"CHEMBL61006","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Phenylpropanolamine bitartrate"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL214920","canonicalSmiles":"CC(C)CCOc1ccc(NC(=S)Nc2ccc(OCCC(C)C)cc2)cc1","inchiKey":"BWBONKHPVHMQHE-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TIOCARLIDE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["DATC","Thiocarlide","Tiocarlide"],"crossReferences":{"Wikipedia":["Thiocarlide"],"drugbank":["DB13608"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL22097","canonicalSmiles":"CN1C(=O)C(O)N=C(c2ccccc2Cl)c2cc(Cl)ccc21","inchiKey":"FJIKWRGCXUCUIG-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LORMETAZEPAM","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Chlorotemazepam","Lormetazepam","Methyllorazepam","WY-4082"],"crossReferences":{"Wikipedia":["Lormetazepam"],"drugbank":["DB13872"],"chEBI":["52993"]},"count":5,"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and has 5 investigational indications."}
{"id":"CHEMBL2220482","canonicalSmiles":"C[C@@H](N)[C@H]1O[C@@H](O[C@@H]2[C@@H](O)[C@H](N)C[C@H](N)[C@H]2O[C@H]2O[C@H]([C@@H](C)O)[C@@H](O)[C@H](O)[C@H]2N)[C@H](O)[C@@H]1O","inchiKey":"KJBRSTPUILEBDR-YBNFDXCTSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL2220482","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB15080"]},"childChemblIds":["CHEMBL2206195"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2364639","canonicalSmiles":"COc1cc2c(cc1OC)[C@H]1C[C@@H](OC(=O)[C@@H](N)C(C)C)[C@H](CC(C)C)CN1CC2","inchiKey":"GEJDGVNQKABXKG-CFKGEZKQSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"VALBENAZINE","yearOfFirstApproval":2017,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["NBI-98854","Valbenazine"],"crossReferences":{"DailyMed":["valbenazine%20tosylate"],"drugbank":["DB11915"]},"childChemblIds":["CHEMBL3707248"],"count":3,"linkedTargets":{"rows":["ENSG00000165646"],"count":1},"linkedDiseases":{"rows":["Orphanet_399","EFO_0004280","EFO_0004895"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2017 and has 3 investigational indications."}
{"id":"CHEMBL254432","canonicalSmiles":"CCOC(=O)C1=C(C)NC(=S)N[C@H]1c1cccc(O)c1","inchiKey":"LOBCDGHHHHGHFA-LBPRGKRZSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"S-MENASTROL","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["S-Menastrol","S-menastrol"],"crossReferences":{"drugbank":["DB04331"],"chEBI":["75384"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL255134","canonicalSmiles":"COc1ccc2c(c1)S(=O)(=O)NC(c1c(O)c(-c3ccccc3)nn(CCC(C)C)c1=O)=N2","inchiKey":"HTTWNUWLEOXVKB-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL255134","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB06974"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL259771","canonicalSmiles":"CCOC(=O)[C@H](C)NP(=O)(N[C@@H](C)C(=O)OCC)c1ccc(-c2nc(N)sc2CC(C)C)o1","inchiKey":"BYKBUQDQTLDNLE-KBPBESRZSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"Mb06322","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Mb06322"],"crossReferences":{"drugbank":["DB05518"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL269259","canonicalSmiles":"CC[C@H](C(=O)N1CCCC[C@H]1C(=O)O[C@H](CCc1ccc(OC)c(OC)c1)c1cccc(OCC(=O)NCCNC(=O)COc2cccc([C@@H](CCc3ccc(OC)c(OC)c3)OC(=O)[C@@H]3CCCCN3C(=O)[C@@H](CC)c3cc(OC)c(OC)c(OC)c3)c2)c1)c1cc(OC)c(OC)c(OC)c1","inchiKey":"GQLCLPLEEOUJQC-ZTQDTCGGSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"RIMIDUCID","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AP-1903","AP1903","Rimiducid"],"crossReferences":{"drugbank":["DB04974"]},"count":9,"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 9 investigational indications."}
{"id":"CHEMBL276815","canonicalSmiles":"Cc1onc(O)c1C[C@H](N)C(=O)O","inchiKey":"UUDAMDVQRQNNHZ-YFKPBYRVSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"(S)-AMPA","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["11111209","11113389","11113390","11113428","26751663"],"Wikipedia":["AMPA"],"drugbank":["DB02057"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL28319","canonicalSmiles":"Nc1ccccc1O","inchiKey":"CDAWCLOXVUBKRW-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"QUESTIOMYCIN B","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["o-aminophenol","ortho-aminophenol"],"crossReferences":{"PubChem":["144208130","17388842","85148769"],"Wikipedia":["2-Aminophenol"],"drugbank":["DB01726"],"chEBI":["18112"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL297053","canonicalSmiles":"CN(Cc1cc2ccccc2n1C)C(=O)/C=C/c1ccc(N)nc1","inchiKey":"AKFPMLBVLWZSQX-CSKARUKUSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL297053","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB01865"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3039504","canonicalSmiles":"CCS(=O)(=O)O.COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\\Nc1ccc(N(C)C(=O)CN2CCN(C)CC2)cc1)c1ccccc1","inchiKey":"MMMVNAGRWOJNMW-FJBFXRHMSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"NINTEDANIB ESYLATE","yearOfFirstApproval":2014,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL502835","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Ofev"],"synonyms":["Nintedanib esylate"],"crossReferences":{"DailyMed":["nintedanib%20esylate"],"chEBI":["85170"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 2014."}
{"id":"CHEMBL3039509","canonicalSmiles":"CC[C@H]1OC(=O)C[C@@H](O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)[C@@H](O)[C@H](N(C)C)[C@H]2O)[C@@H](CCN2CCCCC2)C[C@@H](C)C(=O)/C=C/C(C)=C/[C@@H]1CN1CCCCC1","inchiKey":"HNDXPZPJZGTJLJ-UEJFNEDBSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TILDIPIROSIN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Zuprevo"],"synonyms":["Tildipirosin"],"crossReferences":{"drugbank":["DB11470"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL312448","canonicalSmiles":"Cc1cc(C(C)(C)C)cc(C)c1CC1=NCCN1","inchiKey":"HUCJFAOMUPXHDK-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"XYLOMETAZOLINE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Xylometazoline"],"crossReferences":{"PubChem":["11111974","11111975","174007471","50100368","50104259","90340774"],"Wikipedia":["Xylometazoline"],"drugbank":["DB06694"],"chEBI":["10082"]},"childChemblIds":["CHEMBL1256400"],"count":3,"approvedIndications":["EFO_0005751","HP_0001742"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and is indicated for eye allergy and nasal obstruction and has 1 investigational indication."}
{"id":"CHEMBL3187229","canonicalSmiles":"C#C[C@]1(OC(=O)CCCCCC)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@@H]4[C@H]3CC[C@@]21C","inchiKey":"APTGJECXMIKIET-WOSSHHRXSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL3187229","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["144206578"],"drugbank":["DB14678"],"chEBI":["34894"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL319497","canonicalSmiles":"NCCCC[C@@H](N)C(=O)O","inchiKey":"KDXKERNSBIXSRK-RXMQYKEDSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL319497","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["29216420"],"drugbank":["DB03252"],"chEBI":["16855"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL324455","canonicalSmiles":"CC(=O)Nc1c(O)cc(C(=O)O)cc1[N+](=O)[O-]","inchiKey":"JIDRTCHFBHJIDG-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL324455","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08570"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3260563","canonicalSmiles":"Cc1ccc(Sc2ccccc2N2CCNCC2)c([11CH3])c1","inchiKey":"YQNWZWMKLDQSAC-JVVVGQRLSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL3260563","maximumClinicalTrialPhase":0,"parentId":"CHEMBL2104993","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3301615","canonicalSmiles":"Cl.c1ccc2cc([C@]34CNC[C@H]3C4)ccc2c1","inchiKey":"ACVMJAJGCQUPKX-LIOBNPLQSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CENTANAFADINE HYDROCHLORIDE","maximumClinicalTrialPhase":2,"parentId":"CHEMBL3301621","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Centanafadine hydrochloride","DOV 216,419","DOV 216,419 HYDROCHLORIDE","DOV-216419 HYDROCHLORIDE","EB-1020","EB-1020 HYDROCHLORIDE"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL3301674","canonicalSmiles":"CCCCCNC(=O)c1coc([C@@H]2[C@H]3CC[C@H](O3)[C@@H]2Cc2ccccc2CCC(=O)[O-])n1.[Na+]","inchiKey":"WOHSQDNIXPEQAE-QBKVZTCDSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"IFETROBAN SODIUM","maximumClinicalTrialPhase":2,"parentId":"CHEMBL3301673","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BMS-180291-02","Ifetroban sodium"],"count":2,"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL3317857","canonicalSmiles":"O=C(O)C[C@@H]1CC[C@H](NC(=O)Cc2cccs2)B(O)O1","inchiKey":"IOOWNWLVCOUUEX-WPRPVWTQSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"VABORBACTAM","yearOfFirstApproval":2017,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["RPX-7009","RPX7009","Vaborbactam"],"crossReferences":{"DailyMed":["vaborbactam"],"drugbank":["DB12107"]},"count":3,"approvedIndications":["EFO_0003103"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2017 and is indicated for urinary tract infection and has 2 investigational indications."}
{"id":"CHEMBL333950","canonicalSmiles":"C=C1/C(=C\\C=C2/CCC[C@]3(C)[C@@H]([C@H](C)OCCC(C)(C)O)CC[C@@H]23)C[C@@H](O)C[C@@H]1O","inchiKey":"DTXXSJZBSTYZKE-ZDQKKZTESA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MAXACALCITOL","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Prezios"],"synonyms":["1alpha,25-dihydroxy-22-oxavitamin d3","22-oxacalcitriol","Maxacalcitol","OCT","SCH 209579","SCH-209579"],"crossReferences":{"PubChem":["144206553"]},"childChemblIds":["CHEMBL4303452"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL3358841","canonicalSmiles":"CC(C)[C@]12O[C@H]1[C@@H]1O[C@]13[C@]1(O[C@H]1C[C@@]1(O)C4=C(CC[C@]31C)C(=O)OC4)[C@@H]2O","inchiKey":"OKRSVUYYCJPECG-LFGMFVMYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL3358841","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB12252"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL352764","canonicalSmiles":"CC(C)SCC[C@@H](N)[C@H](O)C(=O)NNC(=O)c1cccc(Cl)c1","inchiKey":"BYBVYIPUGPZRSX-OLZOCXBDSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"A-357300","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["A-357300"],"crossReferences":{"drugbank":["DB07377"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3544947","canonicalSmiles":"CC(C)(C(N)=O)C1CCN(CCC2(c3ccc(Cl)c(Cl)c3)CN(C(=O)Cc3cc(C(F)(F)F)cc(C(F)(F)F)c3)CCO2)CC1","inchiKey":"ZLNYUCXXSDDIFU-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BURAPITANT","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Burapitant","SSR-240600","SSR240600C","Ssr240600"],"count":1,"linkedTargets":{"rows":["ENSG00000115353"],"count":1},"linkedDiseases":{"rows":["EFO_1000781"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL3544978","canonicalSmiles":"C[C@@H]1O[C@H](C)CN2c3c(cc4c(N5C(=O)OC[C@@H]5C)noc4c3F)CC3(C(=O)NC(=O)NC3=O)[C@@H]12","inchiKey":"ZSWMIFNWDQEXDT-ZESJGQACSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ZOLIFLODACIN","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AZD-0914","AZD0914","ETX-0914","ETX0914","Zoliflodacin"],"crossReferences":{"drugbank":["DB12817"]},"count":2,"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL3545051","drugType":"Small molecule","blackBoxWarning":false,"name":"CEP-37440","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Cep-37440"],"count":1,"linkedTargets":{"rows":["ENSG00000171094","ENSG00000169398"],"count":2},"linkedDiseases":{"rows":["EFO_0000616"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL3545108","canonicalSmiles":"O=C(NCC12CC3CC(CC(C3)C1)C2)c1cc(CCCNCCCO)ccc1Cl","inchiKey":"HSQAARMBHJCUOK-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AZD9056","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AZD9056","Azd 9056","Azd9056"],"crossReferences":{"drugbank":["DB12594"]},"childChemblIds":["CHEMBL3415305"],"count":1,"linkedTargets":{"rows":["ENSG00000089041"],"count":1},"linkedDiseases":{"rows":["EFO_0000685"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL3545120","drugType":"Small molecule","blackBoxWarning":false,"name":"CE-245677","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Ce-245677"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3545337","canonicalSmiles":"CCN(CC)CCNc1ccc2ncn3c4ccc(O)cc4c(=O)c1c23.Cl.Cl.O","inchiKey":"XJYNBZQTAZDMHZ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"C-1311","maximumClinicalTrialPhase":2,"parentId":"CHEMBL338604","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Symadex"],"synonyms":["C-1311"],"description":"Small molecule drug with a maximum clinical trial phase of II."}
{"id":"CHEMBL368347","canonicalSmiles":"COc1cc(C[C@@H](CO)[C@H](CO)Cc2ccc(O)c(OC)c2)ccc1O","inchiKey":"PUETUDUXMCLALY-HOTGVXAUSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"(+)-SECOISOLARICIRESINOL","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["(+)-secoisolariciresinol","Secoisolariciresinol"],"crossReferences":{"Wikipedia":["Secoisolariciresinol"],"drugbank":["DB12179"],"chEBI":["65004"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL3686884","canonicalSmiles":"CNC(=O)n1ccc2cc(Oc3ccnc(NC(=O)c4ccc(C5CCN(CCO)CC5)cc4)c3)c(OCCOC)cc21","inchiKey":"IBHOLSBDZMIPPT-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"E-7090","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["E-7090","E7090"],"count":3,"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL3707215","canonicalSmiles":"CN(C)CCOC(c1ccccc1)c1ccccc1.Cn1c(=O)c2c(ncn2CC(=O)O)n(C)c1=O","inchiKey":"UFKLOBYBVCBTBP-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ETANAUTINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Etanautine"],"crossReferences":{"DrugCentral":["4534"],"drugbank":["DB13636"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL3707239","canonicalSmiles":"Cn1c(=O)c2c(ncn2CCOC(=O)c2cccnc2)n(C)c1=O","inchiKey":"ZWIAODBBEZGVPY-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ETOFYLLINE NICOTINATE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Etofylline nicotinate"],"crossReferences":{"drugbank":["DB13842"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL3707287","canonicalSmiles":"O=C([O-])c1cccnc1.O=C([O-])c1cccnc1.O=C([O-])c1cccnc1.[Al+3]","inchiKey":"NSFYKDVWNTWJOK-UHFFFAOYSA-K","drugType":"Small molecule","blackBoxWarning":false,"name":"ALUMINIUM NICOTINATE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Aluminium nicotinate"],"crossReferences":{"DrugCentral":["4764"],"drugbank":["DB13576"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3707314","drugType":"Protein","blackBoxWarning":false,"name":"METHOXY POLYETHYLENE GLYCOL-EPOETIN BETA","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Mircera"],"synonyms":["Methoxy polyethylene glycol-epoetin beta","R-744","R744"],"crossReferences":{"DailyMed":["methoxy%20polyethylene%20glycol-epoetin%20beta"]},"count":3,"approvedIndications":["EFO_0003884","EFO_0004272"],"linkedTargets":{"rows":["ENSG00000187266"],"count":1},"linkedDiseases":{"rows":["EFO_0003086","EFO_0003884","EFO_0004272"],"count":3},"description":"Protein drug with a maximum clinical trial phase of IV (across all indications) and is indicated for chronic kidney disease and anemia (phenotype) and has 1 investigational indication."}
{"id":"CHEMBL3707326","drugType":"Antibody","blackBoxWarning":false,"name":"BUROSUMAB","yearOfFirstApproval":2018,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Crysvita"],"synonyms":["Burosumab","Burosumab-twza","KRN-23","KRN23"],"crossReferences":{"DailyMed":["burosumab-twza"]},"count":5,"approvedIndications":["HP_0002148","EFO_0004260"],"linkedTargets":{"rows":["ENSG00000118972"],"count":1},"linkedDiseases":{"rows":["Orphanet_437","HP_0002148","EFO_1002027","Orphanet_89936","Orphanet_35125","EFO_0004260"],"count":6},"description":"Antibody drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2018 and is indicated for bone disease and hypophosphatemia and has 3 investigational indications."}
{"id":"CHEMBL3707329","canonicalSmiles":"C=C[C@H]1CN2CC[C@H]1C[C@H]2[C@H](O)c1ccnc2ccc(OC)cc12.C=C[C@H]1CN2CC[C@H]1C[C@H]2[C@H](O)c1ccnc2ccc(OC)cc12.C=C[C@H]1CN2CC[C@H]1C[C@H]2[C@H](O)c1ccnc2ccc(OC)cc12.O=P(O)(O)O.O=P(O)(O)O","inchiKey":"JGWCVXDJEMKYEA-INGJVHGESA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"QUININE PHOSPHATE","maximumClinicalTrialPhase":0,"parentId":"CHEMBL170","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Quinine phosphate"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3707359","drugType":"Unknown","blackBoxWarning":false,"name":"DAXIBOTULINUMTOXINA","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Daxibotulinumtoxina","RTI-150","RTI150","RTT150"],"count":1,"description":"Unknown drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL3707390","canonicalSmiles":"CN1C(=O)N(C)C2C1N(C)C(=O)N2C","inchiKey":"XIUUSFJTJXFNGH-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MEBICAR","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Tetramethylglycoluril"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL380955","canonicalSmiles":"CN(C)C(=O)N1CC(c2cc(F)ccc2F)=C[C@H]1c1ccccc1","inchiKey":"WFFMEXQHWXEKBV-SFHVURJKSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL380955","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08246"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3833363","drugType":"Small molecule","blackBoxWarning":false,"name":"CERIUM OXALATE","maximumClinicalTrialPhase":0,"parentId":"CHEMBL3990854","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Cerium oxalate"],"crossReferences":{"DrugCentral":["4403"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL391910","canonicalSmiles":"C[C@H](CCc1ccc(O)cc1)NC(=O)Cc1c(-c2ccccc2)[nH]c2ccccc12","inchiKey":"APLJSSOXDWUNGV-GOSISDBHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL391910","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07991"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3920982","canonicalSmiles":"O=C(O)c1ccc(C2(NC(=O)C3CC4(CCN3Cc3ccc(C(F)(F)F)cc3)CC4)CC2)cc1","inchiKey":"CADWTPLFEZSAHM-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CR-6086","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CR-6086","CR6086","Cr-6086","Cr6086"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL3939295","canonicalSmiles":"C=CC(=O)Nc1cc(N2CCN(CC)CC2)ccc1Nc1cc(N(C)C(=O)Nc2c(Cl)c(OC)cc(OC)c2Cl)ncn1","inchiKey":"MBWRLLRCTIYXDW-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"H3B-6527","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["H3B-6527","H3b 6527","H3b-6527"],"crossReferences":{"drugbank":["DB15169"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL394826","canonicalSmiles":"CNC(=O)c1cc(Oc2ccc3nc(Nc4ccc(Cl)c(C(F)(F)F)c4)[nH]c3c2)ccn1","inchiKey":"ZJLSMLDOCGOURY-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL394826","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB06938"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL395091","canonicalSmiles":"CN[C@]1(c2ccccc2Cl)CCCCC1=O","inchiKey":"YQEZLKZALYSWHR-ZDUSSCGKSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ESKETAMINE","yearOfFirstApproval":2019,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Esketamine"],"crossReferences":{"DailyMed":["esketamine%20hydrochloride"],"PubChem":["144206757"],"drugbank":["DB11823"],"chEBI":["60799"]},"childChemblIds":["CHEMBL2364609"],"count":7,"approvedIndications":["MONDO_0002050","EFO_0003761"],"linkedTargets":{"rows":["ENSG00000183454","ENSG00000161509","ENSG00000273079","ENSG00000116032","ENSG00000105464","ENSG00000176884","ENSG00000198785"],"count":7},"linkedDiseases":{"rows":["EFO_0005854","EFO_0003086","HP_0000360","EFO_0003890","MONDO_0002050","MONDO_0002009","EFO_0001421","EFO_0003761","EFO_0006510","EFO_0003843","EFO_0000311"],"count":11},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2019 and is indicated for unipolar depression and depressive disorder and has 5 investigational indications."}
{"id":"CHEMBL3982690","canonicalSmiles":"Cc1noc(C)c1-c1cc(C(O)(c2ccccn2)c2ccccn2)c2nc(C3CC3)[nH]c2c1","inchiKey":"CMSUJGUHYXQSOK-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ALOBRESIB","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Alobresib","Gs 5829","Gs-5829"],"crossReferences":{"drugbank":["DB14970"]},"count":3,"description":"Small molecule drug with a maximum clinical trial phase of I (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL398435","canonicalSmiles":"CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(F)c(F)c2)c2nnn([C@@H]3C[C@H](OCCO)[C@@H](O)[C@H]3O)c2n1","inchiKey":"OEKWJQXRCDYSHL-FNOIDJSQSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"TICAGRELOR","yearOfFirstApproval":2011,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Brilinta","Brilique"],"synonyms":["AR-C126532XX","AZD-6140","AZD6140","Ticagrelor"],"crossReferences":{"DailyMed":["ticagrelor"],"Wikipedia":["Ticagrelor"],"drugbank":["DB08816"],"chEBI":["68558"]},"count":21,"approvedIndications":["HP_0004419","EFO_0005672"],"linkedTargets":{"rows":["ENSG00000169313"],"count":1},"linkedDiseases":{"rows":["EFO_0004214","EFO_0003086","Orphanet_232","EFO_0000275","EFO_0000266","EFO_0003913","EFO_0003914","EFO_0008585","EFO_0003870","EFO_0000712","EFO_0003884","HP_0004419","EFO_0000400","EFO_0008586","EFO_0000685","HP_0001685","EFO_0001645","EFO_0000556","GO_0070527","EFO_0000319","EFO_0002615","EFO_0003106","MONDO_0100096","MONDO_0000831","EFO_0008583","EFO_0007328","EFO_0000612","EFO_0000341","HP_0031273","EFO_0001360","EFO_0005672","EFO_0004265"],"count":32},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2011 and is indicated for recurrent thrombophlebitis and acute coronary syndrome and has 19 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL3989407","canonicalSmiles":"CN1CCC[C@H]1CCNC(=O)c1cn2c3cc4ccccc4cc3oc3c(N4CCC(c5cnccn5)C4)c(F)cc(c1=O)c32","inchiKey":"WOQIDNWTQOYDLF-CGAIIQECSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"QUARFLOXIN","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CX-3543","Itarnafloxin","Quarfloxin"],"crossReferences":{"drugbank":["DB06638"]},"count":3,"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL3989476","canonicalSmiles":"CC[C@@]1(OC(=O)[C@H](C)NC(=O)COCCOCC(=O)N[C@@H](C)C(=O)O[C@]2(CC)C(=O)OCc3c2cc2n(c3=O)Cc3cc4ccccc4nc3-2)C(=O)OCc2c1cc1n(c2=O)Cc2cc3ccccc3nc2-1","inchiKey":"DZNNFZGDBUXWMV-ZUWDIFAMSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PEGAMOTECAN","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Prothecan"],"synonyms":["EZ-246","Pegamotecan"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL3989825","canonicalSmiles":"CC1(C)N=C(N)N=C(N)N1c1ccc(Cl)cc1.CC1(C)N=C(N)N=C(N)N1c1ccc(Cl)cc1.O=C(O)c1cc2ccccc2c(Cc2c(O)c(C(=O)O)cc3ccccc23)c1O","inchiKey":"LUNRMKZYOGNOTR-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CYCLOGUANIL PAMOATE","maximumClinicalTrialPhase":4,"parentId":"CHEMBL747","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["CI-501","CN-14,329-23A","Chloroguanide triazine pamoate","Cycloguanil embonate","Cycloguanil pamoate","PAM-MR-807-23A"],"count":1,"approvedIndications":["EFO_0001068"],"description":"Small molecule drug with a maximum clinical trial phase of IV and is indicated for malaria."}
{"id":"CHEMBL3990001","drugType":"Antibody","blackBoxWarning":false,"name":"COSFROVIXIMAB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Zmapp"],"synonyms":["Cosfroviximab","c13C6-FR1"],"count":1,"description":"Antibody drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL3990020","drugType":"Gene","blackBoxWarning":false,"name":"VADACABTAGENE LERALEUCEL","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["JCAR-015","JCAR015","Vadacabtagene leraleucel"],"count":1,"description":"Gene drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL409038","canonicalSmiles":"Nc1nccc(-c2ccc3noc(-c4ccc(Cl)cc4)c3c2)n1","inchiKey":"AQVFETGXIRKVAQ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL409038","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["124950700"],"drugbank":["DB08707"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL4093031","canonicalSmiles":"CNC(=O)c1c(-c2ccc(F)cc2)oc2ccc(-c3cc(C(=O)NC4(c5ncccn5)CC4)ccc3C)c(F)c12","inchiKey":"LZAUGCMVNLZVJV-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BMS-929075","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Bms-929075"],"crossReferences":{"drugbank":["DB14950"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL410414","canonicalSmiles":"CN(Cc1ccccc1)C(=O)[C@@H](NC(=O)c1cc2cc(NC(=O)c3ccccc3-c3ccc(C(F)(F)F)cc3)ccc2n1C)c1ccccc1","inchiKey":"TUOSYWCFRFNJBS-BHVANESWSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DIRLOTAPIDE","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CP-742,033","CP-742033","Dirlotapide"],"crossReferences":{"Wikipedia":["Dirlotapide"],"drugbank":["DB11399"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL415879","canonicalSmiles":"c1cnc2c(c1)ccc1cccnc12","inchiKey":"DGEZNRSVGBDHLK-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PHENANTHROLINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["1,10-Phenanthroline"],"crossReferences":{"PubChem":["11110642","11533040","124876930","144209196","144213428","17388818","17405543","4252490","50105542","50105543","50105544","85230866","90341127"],"Wikipedia":["Phenanthroline"],"drugbank":["DB02365"],"chEBI":["44975"]},"childChemblIds":["CHEMBL1969792","CHEMBL1255788","CHEMBL3183967","CHEMBL1522486"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL4209157","canonicalSmiles":"O=C1CCc2c(Oc3ccc4c(c3)[C@@H]3[C@H](O4)[C@H]3c3nc4cc(C(F)(F)F)ccc4[nH]3)ccnc2N1","inchiKey":"NGFFVZQXSRKHBM-FKBYEOEOSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LIFIRAFENIB","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BGB-283","Bgb 283","Bgb-283","Lifirafenib"],"crossReferences":{"drugbank":["DB14773"]},"childChemblIds":["CHEMBL4298146"],"count":1,"linkedTargets":{"rows":["ENSG00000157764"],"count":1},"linkedDiseases":{"rows":["EFO_0000616"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL425386","canonicalSmiles":"O=C(O)c1ccc(-c2ccccc2[N+](=O)[O-])o1","inchiKey":"XUFDYUSOQQYQRL-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL425386","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07408"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL426084","canonicalSmiles":"NC(=O)c1ccc2c(c1O)[C@]13CCN(CC4CC4)[C@H](C2)[C@]1(O)CCC(=O)C3","inchiKey":"RYIDHLJADOKWFM-MAODMQOUSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SAMIDORPHAN","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ALKS 33","ALKS-33","ALKS-5461 COMPONENT SAMIDORPHAN","Alks-33","RDC-0313","RDC-0313-00","Samidorphan"],"crossReferences":{"drugbank":["DB12543"]},"childChemblIds":["CHEMBL2105749","CHEMBL471243"],"count":4,"linkedTargets":{"rows":["ENSG00000112038"],"count":1},"linkedDiseases":{"rows":["EFO_0005203","EFO_0002610","EFO_0000692","EFO_0003829"],"count":4},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL4297367","canonicalSmiles":"C#Cc1cccc(-c2cc(=O)n(C)c3ccc([C@](O)(c4ccc(Cl)cc4)c4cncn4C)cc23)c1","inchiKey":"JAHDAIPFBPPQHQ-GDLZYMKVSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CP-609754","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CP-609,754","Cp-609,754","Cp-609754","LNK-754","Lnk-754","OSI-754"],"crossReferences":{"drugbank":["DB12640"]},"count":2,"description":"Small molecule drug with a maximum clinical trial phase of I (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL4297400","canonicalSmiles":"CCOC(=O)C(C)(C)NP(=O)(NC(C)(C)C(=O)OCC)c1ccc(-c2nc(N)sc2C(=O)C(C)(C)C)o1","inchiKey":"CTKZZUXRWBCFEI-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MB-07803","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["MB 07803","Mb-07803","Mb07803"],"crossReferences":{"drugbank":["DB05053"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL4297489","canonicalSmiles":"Cc1nn(C)cc1CN1CCC(c2ccc(C(=O)Nc3ccccc3N)cc2)CC1","inchiKey":"JHDZMASHNBKTPS-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CXD-101","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CXD-101","CXD101","Cxd-101","Cxd101"],"count":2,"description":"Small molecule drug with a maximum clinical trial phase of I (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL4297566","drugType":"Oligonucleotide","blackBoxWarning":false,"name":"CASIMERSEN","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Casimersen","EXON-45: NG-12-0064","SRP-4045"],"count":1,"description":"Oligonucleotide drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL4297609","canonicalSmiles":"Cc1cc(-c2ccccc2)c(C(=O)C(=O)Nc2ccc(N3CCN(c4ncc(F)cn4)CC3)cc2)n1C","inchiKey":"SUFPWYYDCOKDLL-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"OLOROFIM","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["F901318","Olorofim"],"crossReferences":{"drugbank":["DB15245"]},"count":3,"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL4297643","canonicalSmiles":"Cc1cccc(/C=N/Nc2cc(N3CCOCC3)nc(OCCc3ccccn3)n2)c1","inchiKey":"HSKAZIJJKRAJAV-KOEQRZSOSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"APILIMOD","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Apilimod","STA 5326","STA-5326","Sta-5326"],"crossReferences":{"drugbank":["DB05611"]},"count":2,"linkedTargets":{"rows":["ENSG00000115020"],"count":1},"linkedDiseases":{"rows":["MONDO_0100096","Orphanet_1572","EFO_0000384"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL4297672","drugType":"Small molecule","blackBoxWarning":false,"name":"METHYLCOBALAMIN","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Mecobalamin","Methyl b12","Methylcobalamin"],"count":2,"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL4297694","drugType":"Protein","blackBoxWarning":false,"name":"ANFIBATIDE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Anfibatide"],"count":2,"description":"Protein drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL4297753","drugType":"Unknown","blackBoxWarning":false,"name":"FERROUS BISGLYCINATE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Ferrous bisglycinate"],"count":1,"description":"Unknown drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL4297840","drugType":"Antibody","blackBoxWarning":false,"name":"TISLELIZUMAB","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BGB-A317","BGN-1","BGN1","Bgb-a317","JHL-2108","JHL2108","Tislelizumab"],"count":12,"description":"Antibody drug with a maximum clinical trial phase of III (across all indications) and has 12 investigational indications."}
{"id":"CHEMBL4297977","drugType":"Unknown","blackBoxWarning":false,"name":"HAEMOPHILUS INFLUENZAE TYPE B STRAIN 20752 CAPSULAR POLYSACCHARIDE TETANUS TOXOID CONJUGATE ANTIGEN","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Haemophilus influenzae type b strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen","Hiberix"],"count":3,"description":"Unknown drug with a maximum clinical trial phase of III (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL4303321","canonicalSmiles":"CCCCCNC(=N)N/N=C/c1c[nH]c2ccc(OC)cc12.O=C(O)/C=C/C(=O)O","inchiKey":"CPDDZSSEAVLMRY-QUZUWDHUSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL4303321","maximumClinicalTrialPhase":0,"parentId":"CHEMBL76370","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL4303669","canonicalSmiles":"O.O=P(O)(O)C(O)(Cn1ccnc1)P(=O)(O)O","inchiKey":"FUXFIVRTGHOMSO-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL4303669","maximumClinicalTrialPhase":0,"parentId":"CHEMBL924","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL43064","canonicalSmiles":"C(=C/c1ccccc1)\\CN1CCN(C(c2ccccc2)c2ccccc2)CC1","inchiKey":"DERZBLKQOCDDDZ-JLHYYAGUSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CINNARIZINE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Marzine r.f.","Mylan travel sickness","Stugeron","Stugeron fte"],"synonyms":["516 MD","516-MD","Cinnarizine","R 1575","R 516","R-1575","R-516","Stugeron","Stunarone","Stutgin"],"crossReferences":{"PubChem":["144203660","170465920","50103929","56422441","85231348","855570","90340734"],"Wikipedia":["Cinnarizine"],"chEBI":["31403"]},"count":1,"approvedIndications":["HP_0002321"],"linkedTargets":{"rows":["ENSG00000157388","ENSG00000081248","ENSG00000102001","ENSG00000151067","ENSG00000196639"],"count":5},"linkedDiseases":{"rows":["EFO_0005242","HP_0002321"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of IV and is indicated for vertigo."}
{"id":"CHEMBL437765","canonicalSmiles":"CO[C@H]1/C=C/O[C@@]2(C)Oc3c(C)c(O)c4c(O)c(cc(O)c4c3C2=O)NC(=O)/C(C)=C\\C=C\\[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C","inchiKey":"HJYYPODYNSCCOU-ODRIEIDWSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"RIFAMYCIN","yearOfFirstApproval":2018,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["CB-01-11","M-14","Rifamycin","Rifamycin Sv","Rifomycin"],"crossReferences":{"DailyMed":["rifamycin%20sodium"],"drugbank":["DB11753"],"chEBI":["29673"]},"childChemblIds":["CHEMBL2105680"],"count":4,"approvedIndications":["Orphanet_3389","EFO_1001888"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2018 and is indicated for tuberculosis and eye infection and has 2 investigational indications."}
{"id":"CHEMBL456237","canonicalSmiles":"Fc1ccc(-c2c3cccc(C(F)(F)F)c3nn2Cc2ccc(F)cc2Cl)cc1","inchiKey":"KYWWJENKIMRJBI-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LXR-623","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Lxr-623","WAY-252623"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL4594256","drugType":"Small molecule","blackBoxWarning":false,"name":"LOBAPLATIN","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Lobaplatin"],"count":8,"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 8 investigational indications."}
{"id":"CHEMBL4594297","canonicalSmiles":"C[Si](C)(C)c1cc([Si](C)(C)C)c(NC(=O)c2c[nH]c3ccccc3c2=O)cc1O","inchiKey":"TYQIFWXBQYAKCR-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DIROCAFTOR","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Dirocaftor","PTI-808","Pti-808"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4594450","canonicalSmiles":"CC(C)Cc1ccc(C(C)C(=O)O)cc1.N=C(N)NCCC[C@H](N)C(=O)O","inchiKey":"GCCOJNYCFNSJII-VWMHFEHESA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"IBUPROFEN ARGININE","maximumClinicalTrialPhase":0,"parentId":"CHEMBL521","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Ibuprofen arginine"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL4594527","drugType":"Unknown","blackBoxWarning":false,"name":"AVID-200","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AVID-200","AVID200","Avid-200","Avid200"],"count":2,"description":"Unknown drug with a maximum clinical trial phase of I (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL4594552","drugType":"Antibody","blackBoxWarning":false,"name":"CUDAROLIMAB","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Cudarolimab","IBI-101","IBI101","Ibi101"],"count":1,"description":"Antibody drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4594561","drugType":"Enzyme","blackBoxWarning":false,"name":"INVAC-1, A DOUBLE STRANDED DNA PLASMID VACCINE CONSTRUCT ENCODING UBIQUITIN-HUMAN TELOMERASE REVERSE TRANSCRIPTASE (HTERT) FUSION PROTEIN","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["INVAC-1","Invac-1","Invac-1, a double stranded dna plasmid vaccine construct encoding ubiquitin-human telomerase reverse transcriptase (htert) fusion protein"],"count":2,"description":"Enzyme drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL460831","canonicalSmiles":"N[C@@H](CCC(=O)N[C@@H](CS)C(=O)O)C(=O)O","inchiKey":"RITKHVBHSGLULN-WHFBIAKZSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"Gamma-Glutamyl-Cysteine","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Gamma-Glutamyl-Cysteine"],"crossReferences":{"Wikipedia":["Gamma-Glutamylcysteine"],"drugbank":["DB03408"],"chEBI":["17515"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL46486","canonicalSmiles":"C[N+](C)(C)C","inchiKey":"QEMXHQIAXOOASZ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TETRAMETHYLAMMONIUM ION","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Tetramethyl-Ammonium"],"crossReferences":{"drugbank":["DB03095"],"chEBI":["46020"]},"childChemblIds":["CHEMBL2288325","CHEMBL1209651","CHEMBL3187523"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL470365","canonicalSmiles":"Cc1ccccc1[C@H]1CCCN1C(=O)c1ccc(O)cc1O","inchiKey":"TWODFUZHWYZBHZ-MRXNPFEDSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL470365","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08442"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL476189","canonicalSmiles":"CC(C)=CCNc1ncnc2[nH]cnc12","inchiKey":"HYVABZIGRDEKCD-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"N6-(2-Isopentenyl)Adenine","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["N6-(2-Isopentenyl)Adenine"],"crossReferences":{"PubChem":["4253531","554384"],"drugbank":["DB08768"],"chEBI":["17660"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL478464","canonicalSmiles":"Nc1cccc(Sc2ccc(/C=C/C(=O)N3CCOCC3)c(C(F)(F)F)c2C(F)(F)F)c1","inchiKey":"KLSZVPNVFKKIRD-FNORWQNLSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL478464","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07486"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL482581","canonicalSmiles":"O=c1ccc2cc(O[C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)c(O)cc2o1","inchiKey":"XHCADAYNFIFUHF-TVKJYDDYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ESCULIN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["NSC-26665"],"crossReferences":{"PubChem":["144204004","26754256"],"Wikipedia":["Aesculin"],"drugbank":["DB13155"],"chEBI":["4853"]},"childChemblIds":["CHEMBL1718108"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL490814","canonicalSmiles":"C[C@H](Nc1cc2c(-c3cc(Cl)cc(CCCO)c3)noc2cn1)c1ccccc1","inchiKey":"MMGKIHLBFPJYJL-HNNXBMFYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL490814","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB06897"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL491960","canonicalSmiles":"O=c1[nH]c(=S)[nH]c(-c2ccccc2)c1Cc1c(O)ccc2ccccc12","inchiKey":"RVNSQVIUFZVNAU-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CAMBINOL","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Cambinol"],"crossReferences":{"PubChem":["410126","4253568","90341827"],"drugbank":["DB15493"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL495072","canonicalSmiles":"Clc1ccc(CCC2(Cn3ccnc3)OCCO2)cc1","inchiKey":"NPIOYRIZNLPLDH-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL495072","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB06914"]},"childChemblIds":["CHEMBL541899"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL526872","canonicalSmiles":"CN[C@@H](C)[C@H](O)c1ccccc1.O=S(=O)(O)O","inchiKey":"XVPDSDYVNYOVMP-GNAZCLTHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"EPHEDRINE HEMISULFATE","maximumClinicalTrialPhase":0,"parentId":"CHEMBL211456","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["(-)-Ephedrine Hemisulfate","Ephedrine Sulfate"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL537968","canonicalSmiles":"Cc1cccc(-c2nc(Nc3ccc4[nH]ncc4c3)c3ccccc3n2)n1","inchiKey":"HNHRWNUXTCATSG-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL537968","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08450"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL540851","canonicalSmiles":"Cl.N=C(N)NC(=O)c1nc(Cl)c(N)nc1N","inchiKey":"ACHKKGDWZVCSNH-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL540851","maximumClinicalTrialPhase":0,"parentId":"CHEMBL945","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["144208584","144213385","17389181","26747441","50105840","56422423","855999"],"chEBI":["84743"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL55624","canonicalSmiles":"Cc1oc(-c2ccccc2)nc1CCC(=O)c1ccc(CC2SC(=O)NC2=O)cc1","inchiKey":"QQKNSPHAFATFNQ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DARGLITAZONE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Darglitazone"],"crossReferences":{"PubChem":["170466177"],"drugbank":["DB14034"]},"childChemblIds":["CHEMBL2106162"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL600","canonicalSmiles":"CC(=O)N[C@@H](CS)C(=O)O","inchiKey":"PWKSKIMOESPYIA-BYPYZUCNSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ACETYLCYSTEINE","yearOfFirstApproval":1963,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["A-cys","Acc-600","Acetadote","Acetylcysteine","Airbron","Cetylev","En-cys","Fabrol","Fluimucil","Fluimucil 600","Fluimucil long","Fluimucil n","Ilube","Mucomyst","Mucosil","Mucosil-10","Mucosil-20","N-Acetyl-L-Cysteine","Oronac 600","Parvolex","Respi-nac","Siran","Solmucol","Yournac"],"synonyms":["5052","Acetylcysteine","N-acetyl-l-cysteine","NSC-111180","RK-0202","Rk-0202"],"crossReferences":{"DailyMed":["acetylcysteine"],"PubChem":["144204428","144208276","170464792","26751489","50104028","56423146","855714","90340802"],"Wikipedia":["Acetylcysteine"],"drugbank":["DB06151"],"chEBI":["28939"]},"count":86,"approvedIndications":["EFO_0003966","EFO_1000905","EFO_0004228","Orphanet_586"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1963 and has 4 approved and 82 investigational indications."}
{"id":"CHEMBL642","canonicalSmiles":"CCCC(=O)Nc1ccc(OCC(O)CNC(C)C)c(C(C)=O)c1","inchiKey":"GOEMGAFJFRBGGG-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ACEBUTOLOL","yearOfFirstApproval":1984,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Acebutolol","C07AB04","Sectral"],"crossReferences":{"DailyMed":["acebutolol%20hydrochloride"],"Wikipedia":["Acebutolol"],"drugbank":["DB01193"],"chEBI":["2379"]},"childChemblIds":["CHEMBL1200813"],"count":4,"approvedIndications":["EFO_0000319"],"linkedTargets":{"rows":["ENSG00000043591"],"count":1},"linkedDiseases":{"rows":["EFO_0003777","HP_0004308","EFO_0000319","EFO_1000635","EFO_0000537"],"count":5},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1984 and is indicated for cardiovascular disease and has 3 investigational indications."}
{"id":"CHEMBL671","canonicalSmiles":"S=P(N1CC1)(N1CC1)N1CC1","inchiKey":"FOCVUCIESVLUNU-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"THIOTEPA","yearOfFirstApproval":1959,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Tepadina","Thioplex","Thiotepa"],"synonyms":["NSC-6396","Thiotepa"],"crossReferences":{"DailyMed":["thiotepa"],"PubChem":["124891834","144204952","144214026","26748780","26753739","57260086","72371"],"Wikipedia":["ThioTEPA"],"drugbank":["DB04572"],"chEBI":["9570"]},"count":45,"approvedIndications":["EFO_0000616","EFO_0002422","EFO_0000311"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1959 and has 3 approved and 42 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL70352","canonicalSmiles":"CCN(CC)CCOC(=O)C(O)(c1ccccc1)c1ccccc1","inchiKey":"IVQOFBKHQCTVQV-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BENACTYZINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Benactyzine"],"crossReferences":{"PubChem":["144205218","170466568","29215374"],"Wikipedia":["Benactyzine"],"drugbank":["DB09023"]},"childChemblIds":["CHEMBL1584883"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL73151","canonicalSmiles":"CCN(CC)C(=O)N[C@H]1C[C@@H]2c3cccc4[nH]cc(c34)C[C@H]2N(C)C1","inchiKey":"JOAHPSVPXZTVEP-YXJHDRRASA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TERGURIDE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Terguride"],"crossReferences":{"PubChem":["11533045","144204835"],"drugbank":["DB13399"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL905","canonicalSmiles":"CN(C)CCc1c[nH]c2ccc(Cn3cncn3)cc12","inchiKey":"ULFRLSNUDGIQQP-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"RIZATRIPTAN","yearOfFirstApproval":1998,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Maxalt"],"synonyms":["L-705126","MK-462","MK-462 FREE BASE","Maxalt","Maxalt-Mlt","Rizatriptan"],"crossReferences":{"DailyMed":["rizatriptan%20benzoate"],"PubChem":["144205087","174007052"],"Wikipedia":["Rizatriptan"],"drugbank":["DB00953"],"chEBI":["48273"]},"childChemblIds":["CHEMBL1201032","CHEMBL3989629"],"count":3,"approvedIndications":["EFO_0003821"],"linkedTargets":{"rows":["ENSG00000135312","ENSG00000179546"],"count":2},"linkedDiseases":{"rows":["EFO_0005296","EFO_0003821","EFO_0005295"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1998 and is indicated for migraine disorder and has 2 investigational indications."}
{"id":"CHEMBL911","canonicalSmiles":"Cc1ccc(-c2nc3ccc(C)cn3c2CC(=O)N(C)C)cc1","inchiKey":"ZAFYATHCZYHLPB-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"ZOLPIDEM","yearOfFirstApproval":1992,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Ambien","Zolpidem","Zolpidem civ"],"crossReferences":{"DailyMed":["zolpidem%20tartrate"],"PubChem":["144205024","170465242","26749064"],"Wikipedia":["Zolpidem"],"drugbank":["DB00425"],"chEBI":["10125"]},"childChemblIds":["CHEMBL3989820","CHEMBL1723343"],"count":11,"linkedTargets":{"rows":["ENSG00000113327","ENSG00000163288"],"count":2},"linkedDiseases":{"rows":["EFO_0003888","EFO_0002508","HP_0000726","EFO_0008568","EFO_0001073","EFO_0004698","EFO_0007191","GO_0007568","EFO_0001072","EFO_0003890","MONDO_0002050","EFO_0000673","EFO_0005230","EFO_0000692","EFO_0003918"],"count":15},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1992 and has 11 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL928","canonicalSmiles":"O=C1CN(/N=C/c2ccc(-c3ccc([N+](=O)[O-])cc3)o2)C(=O)[N-]1.[Na+]","inchiKey":"KSRLIXGNPXAZHD-HAZZGOGXSA-M","drugType":"Small molecule","blackBoxWarning":true,"name":"DANTROLENE SODIUM","yearOfFirstApproval":1974,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1201288","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Dantrium","Dantrolene sodium","Revonto","Ryanodex"],"synonyms":["Dantrolene sodium","Dantrolene sodium hydrate","Dantrolene sodium salt hemiheptahydrate","F-440"],"crossReferences":{"DailyMed":["dantrolene%20sodium"],"PubChem":["50106202"]},"count":2,"linkedTargets":{"rows":["ENSG00000198838","ENSG00000196218"],"count":2},"linkedDiseases":{"rows":["EFO_1001340","Orphanet_3463"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1974 and has 2 investigational indications. This drug has a black box warning from the FDA."}
